Journal Report

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS

Download PDF
Journal Information
Journal Title
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
Publisher
ADIS INT LTD
ISSN
1175-3277
E-ISSN
1179-187X
Database
Clarivate
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Effect of Intravenous Nicotinamide Adenine Dinucleotide on Left Ventricular Function After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial
Xiaofan Yu, Jiaoyu Cao, Qizhi Xu et al.
2026-10-30
DOI: 10.1007/s40256-026-00826-4
Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape
Giovanni Vincenzo Gaudio, Giuseppe Derosa, Giuseppe De Angelis et al.
2026-10-21
DOI: 10.1007/s40256-026-00830-8
Beta-Blockers for the Treatment of Arrhythmias: Which Drug for Which Arrhythmia? A State-of-the-Art Narrative Review
Lucian Muresan, Gabriel Cismaru, Stefan Lucian Popa et al.
2026-9-21
DOI: 10.1007/s40256-026-00828-2
Temporal Trends and Predictors of P2Y12 Inhibitor Selection and Switching Following Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
Young Eun Shin, Arun Kumar, Anne Metzger et al.
2026-9-21
DOI: 10.1007/s40256-026-00827-3
SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic Syndrome: Drugs Unifying Heart, Kidney, and Metabolism Pharmacotherapy
Valentina Okhovat, Kamela Lybeshari, Luigi X. Cubeddu et al.
2026-9-15
DOI: 10.1007/s40256-026-00829-1
Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies
José Pablo Miramontes González
2026-8-31
DOI: 10.1007/s40256-026-00825-5
Vutrisiran in Transthyretin Amyloidosis: A Narrative Review
Kamela Lybeshari, Huy Pham, Genevieve Hale
2026-8-20
DOI: 10.1007/s40256-026-00824-6
The Impact of β-Blocker Therapy on Peak VO2 in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis
Juliana Giorgi, Pedro Gomes Batista, Milena dall Witt de Souza et al.
2026-8-19
DOI: 10.1007/s40256-026-00822-8
Zilebesiran in Hypertension: Reversibility, Acute Illness, and Therapeutic Flexibility
Lucas Maciel de Almeida Corrêa, Gabriel Rian Mazur, Clara Belo Gamon Santiago et al.
2026-8-17
DOI: 10.1007/s40256-026-00823-7
Evaluating the Impact of Stair Climbing on Cardiovascular Risk Reduction: A Systematic Review and Meta-analysis
Sophie Paddock, Rathna Veerni, U. Bhalraam et al.
2026-8-13
DOI: 10.1007/s40256-026-00811-x
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 07:28